Arginine as an effective additive in gel permeation chromatography

被引:137
作者
Ejima, D
Yumioka, R
Arakawa, T
Tsumoto, K
机构
[1] Ajinomoto Co Inc, AnimoSci Labs, Dept Appl Res, Kawasaki, Kanagawa 2108681, Japan
[2] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan
[3] Alliance Prot Labs, Thousand Oaks, CA 91360 USA
关键词
gel permeation chromatography; non-specific binding; arginine; aggregation; aggregation suppression;
D O I
10.1016/j.chroma.2005.07.086
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A major problem in gel permeation chromatography (GPC) or size exclusion chromatography is non-specific binding of applied proteins to the column matrix (stationary phase). We have tested an aqueous arginine solution as the GPC mobile phase on silica-based and polymer-based columns, using mouse monoclonal antibody and recombinant human activin, interieukin-6, basic fibroblast growth factor, and interferon-gamma as model proteins. We observed that addition of arginine to the mobile phase improves separation of the proteins and their soluble aggregates from the GPC columns, which suggests that arginine is an effective additive for the GPC mobile phase. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 41 条
  • [11] Chang Byeong S, 2002, Pharm Biotechnol, V13, P1
  • [12] Validation of an SEC-HPLC method for the analysis of rhG-CSF in pharmaceutical formulations
    Codevilla, CF
    Brum, L
    de Oliveira, PR
    Dolman, C
    Rafferty, B
    Dalmora, SL
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2004, 27 (17) : 2689 - 2698
  • [13] Ejima D, 1999, BIOTECHNOL BIOENG, V62, P301, DOI 10.1002/(SICI)1097-0290(19990205)62:3<301::AID-BIT6>3.3.CO
  • [14] 2-N
  • [15] HART RA, 1990, J BIOL CHEM, V265, P12728
  • [16] Hartmen W.K., 2005, ANAL BIOCHEM, V325, P227
  • [17] HERRON JN, 1995, PHARM BIOTECHNOLOGY, V7
  • [18] Hevehan DL, 1997, BIOTECHNOL BIOENG, V54, P221, DOI 10.1002/(SICI)1097-0290(19970505)54:3<221::AID-BIT3>3.0.CO
  • [19] 2-H
  • [20] *ICH, 1999, TECHN REQ REG PHARM